Our studies have shown that deletion of HIF-1α or inhibition of mammalian target of rapamycin (mTOR; known to stabilize HIF-1α) attenuates MPLA-induced increased glycolysis, abolishing the protective effect of MPLA against infection (63, 76). The gene discussed is HIF1A; the disease is infection.